Holen Sie sich die Stockscreener-App
0.2279
6.14%
-0.0149
Handel nachbörslich:
.23
0.0021
+0.92%
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Cosmos Health C-Sept PRO sales exceed $1.3 million at 72% margin - scanx.trade
Is Cosmos Health Inc (COSM) Undervalued After Q2 Earnings Miss? GF Score: 29/100, Revenue at $18.99 Million - GuruFocus
Cosmos Reports Record Q2: Revenue $19.0M, H1 $36.9M; Adjusted Gross Profit Up 58% - TradingView
Cosmos Health Company Profile & Introduction - Moomoo
COSM Looks 40.0% Undervalued on GF Value™ Amid Distribution Deal - GuruFocus
Cosmos Health signs exclusive Saudi distribution deal for supplements By Investing.com - Investing.com South Africa
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Deal With Innova Healthcare - TradingView
Cosmos Health signs exclusive Saudi distribution deal for supplements - Investing.com
Cosmos Health Secures Exclusive Saudi Arabia Distribution Agreement for Sky Premium Life with Innova Healthcare - Quiver Quantitative
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term - NTB Kommunikasjon
COSM Looks 43.9% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
MSN Money - MSN
Cosmos (COSM) Latest Quarter: The EPS Result Is Below Expectation in the Reported Period; Closing Reaction: The Stock Loses 6.20% in the Current UpdateAdjusted Earnings Analysis - Vinanet
Cosmos Health reports record Q2 revenue of $19 million By Investing.com - Investing.com Nigeria
Cosmos Health reports record Q2 revenue of $19 million, up 29% - Investing.com Nigeria
Cosmos Health Q2 Results: EPS Misses Estimate, Sales Rise 29% YoY - scanx.trade
Cosmos Health Reports Q2 2026 - TradingView
Cosmos Health Reports Record Q2 and First-Half 2026 Revenue, Exceeds $75 Million Adjusted Annualized Run-Rate - Quiver Quantitative
BRIEF-Cosmos Health Q2 Gross Profit USD 1.51 Million - TradingView
Press Release: Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Progra - Moomoo
Cosmos Health Q2 Net Loss Widens to $5.4M on Revenue Decline - Minichart
Cosmos Health Inc. (COSM) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Cosmos Health Inc. 2026: Revenue $18.99M, EPS ($0.1) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) grows revenue yet flags doubt about its future - Stock Titan
Cosmos Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Cosmos Health(COSM) Stock Options Chain | Quotes & News - Moomoo
Cosmos Health Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Cosmos Health Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Price to earnings forward of Cosmos Health Inc – DUS:V67A - TradingView
Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cosmos Health (NASDAQ: COSM) CEO swaps $70K debt for 349,825 shares - Stock Titan
Form 4 Cosmos Health Inc. For: 30 July By Investing.com - Investing.com Canada
Cosmos Health Inc. (COSM) CFO swaps $60,000 debt for company stock - Stock Titan
Cosmos Health (NASDAQ: COSM) CEO swaps $140,000 debt for 766,284 new shares - Stock Titan
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels - The Manila Times
Cosmos Health Advances its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C And B2B Channels - marketscreener.com
Cosmos Health Advances Its Technology-Driven Transformation - GlobeNewswire
Cosmos Health develops subscription platform for health products By Investing.com - Investing.com Canada
Cosmos Health develops subscription platform for health products - Investing.com
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Inc (COSM) Cash Flow - TradingKey
Cosmos Health Inc (COSM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cosmos Health Inc (COSM) Income Statement - tradingkey.com
COSM|Cosmos Health Inc|Price:0.205|Chg%:+0.005 - TradingKey
Cosmos Health Inc (COSM) Institutional Confidence - TradingKey
Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cosmos Health Inc (COSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Daily Brief Health Care: Shanghai Shengsheng Pharmaceutical Cold Chain Technology, Akeso, Mitesco Inc, Nagaileben, Repligen Corp, Scribe Therapeutics, Cosmos Health and more - Smartkarma
COSM|Cosmos Health Inc|Price:0.199|Chg%:-0.001 - TradingKey
Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
COSM Marking Huge Growth and Buying Back Shares - Yahoo Finance
COSM|Cosmos Health Inc|Price:0.206|Chg%:+0.006 - TradingKey
Cosmos Health | RW: Registration Withdrawal Request - Moomoo
Cosmos Health Inc. SEC Filing (Jul 22, 2026) - Stock Titan
0.61%
45.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):